Raymond James Cuts Andrx Rating

Analyst Michael Krensavage believes news of accounting irregularities will diminish the valuation investors are willing to apply to the shares

Andrx (ADRX ) says an employee appears to have altered certain accounting records. Raymond James cut its investment opinion on the shares to market perform from strong buy.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.